May 19, 2022 05:23 AM

CHINA

Shanghai Speeds Up Customs Clearance of Covid Vaccines and Materials

By Bao Zhiming and Denise Jia

China National Biotec Group’s mRNA Covid vaccine displayed at the China International Fair for Trade in Services in September 2021.

China National Biotec Group’s mRNA Covid vaccine displayed at the China International Fair for Trade in Services in September 2021.

Shanghai will open a “green channel” to speed up health quarantine approval procedures for Covid-19 vaccines, treatment drugs and other anti-epidemic materials, a customs official said Wednesday.

Shanghai is the center of China’s biomedical research and development industry, and most of the research and development of advanced mRNA vaccines are taking place in the city, which has been battling a surge of Covid cases since March.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Founder of Taiwan Buddhist Monastery Dies

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

China Stories: How Beijing’s Health Care System Battled Covid as Cases Peaked

00:00

00:00/00:00

MOST POPULAR

1: Local Chinese Governments Paid $148 Billion in Interest in 2022

2: Update: Seven Things to Know About China’s Latest IPO System Overhaul

3: In Depth: A Metal Tycoon’s Liquidity Woes Disrupt China’s Copper Trade

4: Opinion: How China’s Chip Industry Should Respond to the U.S.-Japan-Netherlands Alliance

5: China Protests U.S. Downing of Chinese Unmanned Airship, Says It’s ‘Clear Overreaction’

SPONSORED

OR